Related Experiment Video

Updated: Aug 26, 2025

A Method for Measuring RNA N6-methyladenosine Modifications in Cells and Tissues
08:56

A Method for Measuring RNA N6-methyladenosine Modifications in Cells and Tissues

Published on: December 5, 2016

11.0K

The emerging therapeutic target of dynamic and reversible N6-methyladenosine modification during cancer development

Shougeng Liu1,2, Sihong Chen1,2, Chengfang Tang1,2

  • 1Department of Pharmacology, Shenyang Pharmaceutical University, Shenyang, China.

Frontiers in Oncology
|October 13, 2022
PubMed

Insights

N6-methyladenosine (m6A) modification is a key epigenetic process in cells, influencing cancer development and treatment. Targeting m6A regulators shows promise for cancer therapy and overcoming multidrug resistance.

Area of Science:

  • Epigenetics
  • Molecular Biology
  • Oncology

Background:

  • N6-methyladenosine (m6A) is a ubiquitous, dynamic epigenetic modification in eukaryotes.
  • m6A methylation impacts RNA metabolism and cellular fate, including cancer development.
  • m6A regulators are implicated in tumor progression and multidrug resistance.

Purpose of the Study:

  • To review recent studies on m6A modification in cancer.
  • To provide insights into m6A's role in tumor progression, immunity, and drug resistance.
  • To explore m6A regulators as potential therapeutic targets.

Main Methods:

  • Literature review of recent studies on m6A modification in cancer.
  • Analysis of m6A's involvement in tumor progression and immunity.
  • Evaluation of m6A regulators in multidrug resistance and as therapeutic targets.

Main Results:

  • m6A modification is prevalent across RNA metabolism, affecting cancer development.
  • Targeting m6A regulators demonstrates potential in cancer therapy.
  • m6A plays a significant role in multidrug resistance.

Conclusions:

  • m6A modification is a critical factor in cancer biology.
  • m6A regulators represent promising targets for cancer treatment and overcoming resistance.
  • Further research into m6A is crucial for advancing tumor therapy.
Keywords:
RNA epigeneticscancercancer immunityclinical perspectivesm6A modification

More Related Videos

Characterizing RNA Modifications in Single Neurons Using Mass Spectrometry08:45

Characterizing RNA Modifications in Single Neurons Using Mass Spectrometry

Published on: April 21, 2022

2.5K
Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors06:07

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors

Published on: August 5, 2022

2.7K

Related Concept Videos

Biosynthesis of Nucleic Acids01:28

Biosynthesis of Nucleic Acids

Nucleic acid biosynthesis is a fundamental biochemical process that produces the purine and pyrimidine nucleotides essential for DNA and RNA synthesis. This pathway maintains a balanced nucleotide pool, preventing imbalances that could jeopardize genetic integrity and cellular function. Given the crucial role of nucleotides, their synthesis is tightly regulated to ensure proper cellular homeostasis.Purine BiosynthesisThe biosynthesis of purine nucleotides begins with ribose-5-phosphate, a...
143
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.1K
RNA Editing02:23

RNA Editing

RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
9.1K
RNA Stability01:53

RNA Stability

Intact DNA strands can be found in fossils, while scientists sometimes struggle to keep RNA intact under laboratory conditions. The structural variations between RNA and DNA underlie the differences in their stability and longevity. Because DNA is double-stranded, it is inherently more stable. The single-stranded structure of RNA is less stable but also more flexible and can form weak internal bonds. Additionally, most RNAs in the cell are relatively short, while DNA can be up to 250 million...
33.8K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K